SUNBEAM - Analysis and Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of the SUNBEAM - Analysis and Bioinformatics Center (SUNBEAM-ABC) is to establish a mechanistic omics center to support the birth cohort study Systems Biology of Early Atopy (SUNBEAM). The center will assay biologic samples collected within the SUNBEAM cohort using omics and systems biology approaches to identify determinants of atopic disease, focusing on food allergy and atopic dermatitis (AD) in newborns, infants, and very young children. SUNBEAM-ABC will support the SUNBEAM birth cohort study by providing analytic infrastructure for a comprehensive understanding of molecular and cellular pathways that contribute to atopic disease development and to identify early predictive biomarkers.

Only one application per institution is allowed.

Deadlines:

  • Duke Internal: Interested applicants from within Duke should contact dukeiln@duke.edu as early as possible.
  • Letter of Intent Due Date(s): 30 days prior to the application due date

  • Application Due Date: February 15, 2022

RFA-AI-21-060 Expiration Date February 16, 2022

Eligibility

Faculty

Category

Engineering and Physical Sciences
Environmental & Life Sciences
Medical
Medical - Basic Science
Medical - Clinical Science

External Deadline

February 15, 2022